DE181510C - - Google Patents
Info
- Publication number
- DE181510C DE181510C DENDAT181510D DE181510DA DE181510C DE 181510 C DE181510 C DE 181510C DE NDAT181510 D DENDAT181510 D DE NDAT181510D DE 181510D A DE181510D A DE 181510DA DE 181510 C DE181510 C DE 181510C
- Authority
- DE
- Germany
- Prior art keywords
- thebaine
- water
- hydrochloric acid
- ether
- magnesium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FQXXSQDCDRQNQE-VMDGZTHMSA-N Thebaine Chemical class C([C@@H](N(CC1)C)C2=CC=C3OC)C4=CC=C(OC)C5=C4[C@@]21[C@H]3O5 FQXXSQDCDRQNQE-VMDGZTHMSA-N 0.000 claims description 8
- 229930003945 thebaine Natural products 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- -1 thebaine organometallic magnesium compounds Chemical class 0.000 claims description 4
- 229940077744 antacids containing magnesium compounds Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 125000004430 oxygen atoms Chemical group O* 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- NLKNQRATVPKPDG-UHFFFAOYSA-M Potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- QARVLSVVCXYDNA-UHFFFAOYSA-N Bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N Codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 229930013930 alkaloids Natural products 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2H-oxazine Chemical group N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N Benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N Dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- BQJCRHHNABKAKU-KBQPJGBKSA-N Morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 1
- BSKZDJXVMPWPRA-UHFFFAOYSA-N O.[Br] Chemical compound O.[Br] BSKZDJXVMPWPRA-UHFFFAOYSA-N 0.000 description 1
- OOEWZEXEJQEFJO-UHFFFAOYSA-N O.[I] Chemical compound O.[I] OOEWZEXEJQEFJO-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 230000001476 alcoholic Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229930014694 morphine Natural products 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 150000002901 organomagnesium compounds Chemical class 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
PATENTSCHRIFTPATENT LETTERING
KLASSE 12j?. GRUPPECLASS 12y ?. GROUP
Dr. MARTIN FREUND in FRANKFURT a. M.Dr. MARTIN FREUND in FRANKFURT a. M.
Verfahren zur Darstellung von Derivaten des Thebains.Process for the preparation of derivatives of thebaine.
Von den drei Sauerstoffatomen des Thebains sind zwei als Methoxylgruppen enthalten.
Über die Bindungsart der dritten herrscht noch Unklarheit. Bis vor kurzem wurde angenommen, daß dieses dritte Sauerstoffatom
einem Oxazinring
O Of the three oxygen atoms in thebaine, two are contained as methoxyl groups. The type of binding of the third is still unclear. Until recently it was believed that this third oxygen atom was an oxazine ring
O
angehöre, während in neuester Zeit die Ansicht vorherrscht, daß es ähnlich wie
Diphenylenoxydwhile in recent times the prevailing view is that it is similar to
Diphenylene oxide
imin the
gebunden sei. Jedenfalls ist die Art der Bindung mit derjenigen des Sauerstoffs im Äthylenoxyd nicht zu vergleichen.be bound. In any case, the type of bond with that of the oxygen is im Ethylene oxide cannot be compared.
Es ist daher überraschend, daß, wie gefunden wurde, das Thebain in ähnlicher Weise wie Äthylenoxyd mit Grignardlösungen zu reagieren vermag (vergl. Compt. rend. Bd. 136, 1903, S. 1261, Abs. 5 und 6). Bringt man das Alkaloid mit magnesiummetallorganischen Verbindungen zusammen, so lagern sich letztere an das dritte Sauerstoffatom an.It is therefore surprising that as found that thebaine is able to react with Grignard solutions in a similar way as ethylene oxide (cf. Compt. rend. Vol. 136, 1903, p. 1261, paras. 5 and 6). One brings the alkaloid together with organometallic magnesium compounds are stored in this way the latter to the third oxygen atom.
Hierbei werden Zwischenprodukte gebildet, welche beim Zersetzen mit Wasser neue-Basen liefern. Bei Anwendung einer aus Brombenzol, Magnesium und Äther bereiteten Lösung verläuft die Reaktion beispielsweise folgendermaßen:Intermediate products are formed which, when decomposed with water, create new bases deliver. When using a solution prepared from bromobenzene, magnesium and ether, the reaction proceeds, for example as follows:
(CH3 Ok > [C17 H1, N]<0+ C6H5 Mg Br = (C HSO)2 > [C17 H16 N] (CH 3 Ok > [C 17 H 1 , N] <0+ C 6 H 5 Mg Br = (CH S O) 2 > [C 17 H 16 N]
(C H8 0)2> [C17 H15 (CH 8 O) 2 > [C 17 H 15
V6 -"5 V 6 - "5
BrBr
OHOH
5555
Ebenso wie die magnesiumorganischen Verbindungen der aromatischen Reihe reagieren Grignardlösungen, welche mittels Halogenalkyl bezw. Halogenaralkyl bereitet sind. Dieses Verhalten des Thebains ist um so merkwürdiger als Morphin und Codein, welche das dritte Sauerstoffatom ebenso wie Thebain gebunden enthalten, mit Grignardlösungen nicht reagieren.Just like the organomagnesium compounds of the aromatic series react Grignard solutions, which BEZW by means of haloalkyl. Haloaralkyl are prepared. This behavior of thebaine is all the more remarkable than morphine and codeine, which like the third oxygen atom Thebaine contains bound, does not react with Grignard solutions.
Die neuen Verbindungen, welche gleichzeitig basische und saure Eigenschaften besitzen, sollen als Arzneimittel Verwendung finden.The new compounds, which have both basic and acidic properties, should be used as medicinal products.
Um eine möglichst quantitative Umsetzung des Alkaloids zu erzielen, arbeitet man zweckmäßig mit einem Überschuß der magnesiummetallorganischen Verbindung. 50 g Brombenzol werden mit 8 g Magnesium und etwa 400 ecm absolutem Äther zur Reaktion gebracht und in die erhaltene Lösung 50 g ge- 7QIn order to achieve the most quantitative possible conversion of the alkaloid, one works expediently with an excess of the organometallic magnesium compound. 50 g of bromobenzene are combined with 8 g of magnesium and about 400 ecm of absolute ether reacted and 50 g of 7Q
pulvertes Thebain portionsweise unter Verrühren eingetragen. Die Hauptmenge des neuen Produktes ist in dem halbfesten Bodensatz enthalten, von welchem die ätherische Lösung abgegossen wird. Diese schüttelt man mit verdünnter Säure, am besten Essigsäure, durch und fügt die abgetrennte Lösung zum Bodensatz, den man zuvor mit Wasser zersetzt hat, wobei eine klare Lösungpowdered thebaine in portions while stirring registered. The bulk of the new product is contained in the semi-solid sediment, of which the essential Solution is poured off. This is shaken with dilute acid, preferably acetic acid, by and adds the separated solution to the sediment, which has previously been decomposed with water, whereby a clear solution
ίο erhalten wird. Aus dieser läßt sich die, neue Base in Form ihrer Salze auf verschiedenen Wegen leicht erhalten; entweder fällt man durch Jodkalium unmittelbar das schwer lösliche und gut kristallisierende Jodhydrat /C25 H21 NOS · HJ, vom Schmelzpunkt 230 bis 2320) aus, oder man übersättigt zunächst mit Ammoniak, filtriert, extrahiert den Niederschlag mit starkem Alkohol, filtriert nochmals und scheidet aus dem eingeengten FiI-trat durch alkoholische Salzsäure das Chlorhydrat ab (C.2i H27 NOg ■ H Cl + C2H6 O, vom Schmelzpunkt 145 bis 1479). Die Ausbeute ist nahezu quantitativ. Das Produkt liefert, mit Ammoniak zersetzt, die freie Base C25 H21 NO3, welche in fast allen organischen Solventienen leicht löslich ist und aus wenig Alkohol in Säulen vom Schmelzpunkt 62 bis 650 erhalten wird. Sie ist in Alkali löslich; das Natriumsalz kann leicht kristallisiert erhalten werden.ίο is obtained. The new base can easily be obtained from this in the form of its salts in various ways; Either the sparingly soluble and readily crystallizing iodine hydrate (C 25 H 21 NO S · HJ, melting point 230 to 232 0 ) is precipitated directly with potassium iodide, or it is first supersaturated with ammonia, filtered, the precipitate is extracted with strong alcohol, filtered again and separates the hydrochloric acid from the concentrated filtrate with alcoholic hydrochloric acid (C. 2i H 27 NOg. H Cl + C 2 H 6 O, melting point 145 to 147 9 ). The yield is almost quantitative. The product provides, decomposed with ammonia, the free base C 25 H 21 NO 3, which is readily soluble in almost all organic Solventienen and is obtained from a little alcohol in columns of melting point 62 to 65 0th It is soluble in alkali; the sodium salt can easily be obtained in crystallized form.
Das Bromhydrat, aus Wasser kristallisiert, bildet Tafeln, die bei 190 bis 195° aufschäumen. The bromine hydrate, crystallized from water, forms tablets that foam up at 190 to 195 °.
Trägt man Thebain (6,2 Teile) in eine aus Benzylchlorid (10,12 Teile), Magnesium (2 Teile) und Äther (50 Teile) bereitete Lösung, so löst sich beim Digerieren fast alles auf. Man zersetzt mit Wasser, fügt dann Salzsäure (spezifisches Gewicht 1,1) hinzu, trennt die salzsaure Schicht vom Äther, fällt durch Ammoniak die neue Base und schüttelt diese in Äther. Beim Verdunsten bleibt dieselbe ölig zurück; durch nochmaliges Aufnehmen in verdünnte Salzsäure und Fällen mit Ammoniak wird sie als fast weißes Pulver erhalten. In reinem Zustande ist sie in verdünntem Alkali mit gelblicher Farbe löslich, νIf one carries thebaine (6.2 parts) into one of benzyl chloride (10.12 parts), magnesium (2 parts) and ether (50 parts), almost everything dissolves during digestion. Man decomposes with water, then adds hydrochloric acid (specific gravity 1.1), separates the Hydrochloric acid layer from the ether, the new base falls through ammonia and shakes it in ether. When it evaporates, it remains oily; by recording again in dilute hydrochloric acid and cases with ammonia it appears as almost white Powder received. In the pure state it is in a dilute alkali with a yellowish color soluble, ν
Claims (1)
Publications (1)
Publication Number | Publication Date |
---|---|
DE181510C true DE181510C (en) |
Family
ID=445684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DENDAT181510D Active DE181510C (en) |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE181510C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035360A2 (en) * | 1980-02-29 | 1981-09-09 | Gödecke Aktiengesellschaft | 5,6,8,9-Tetrahydro-7H-dibenz(d,f)azonine derivatives, the production thereof and compositions containing them |
-
0
- DE DENDAT181510D patent/DE181510C/de active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035360A2 (en) * | 1980-02-29 | 1981-09-09 | Gödecke Aktiengesellschaft | 5,6,8,9-Tetrahydro-7H-dibenz(d,f)azonine derivatives, the production thereof and compositions containing them |
EP0035360A3 (en) * | 1980-02-29 | 1981-09-23 | Goedecke Ag | 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives, the production thereof and compositions containing them |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3322530A1 (en) | METHOD FOR PRODUCING MONO, BI AND TRICYCLIC AMINO ACIDS | |
DE181510C (en) | ||
DE2541484C3 (en) | 1α-Alkyl-1β- (2-cyanoethyl) - 1,2,3,4,6,7,12,12b β-octahydroindolo [2,3-a] quinolizines | |
DE1695416A1 (en) | Benzomorphan derivatives and processes for their preparation | |
DE2329893A1 (en) | CERTAIN SCOPOLAMMONIUM COMPOUNDS AND PROCEDURES FOR THEIR PRODUCTION | |
DE2166270C3 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
DE2724184C2 (en) | 2- (4-Isobutylphenyl) propionic acid p-hydroxybenzaldehyde semicarbazone ester and process for its preparation | |
DE539784C (en) | Process for the preparation of dyes of the polymethine series | |
DE292284C (en) | ||
DE1445153B2 (en) | 1,2,3,4,5,6-HEXAHYDRO-3- (3-METHYL-2BUTENYL) -6,11-DIMETHYL-8-HYDROXY-2,6METHANO-3-BENZAZOCINE, ITS ACID ADDITIONAL SALTS AND METHOD FOR THEIR PRODUCTION | |
DE224197C (en) | ||
DE2807077C3 (en) | Process for the preparation of 6,73,9,10,11-hexahydro-7, ll-methane-8, ll-dimethylbenzo [b] thieno 23-d azocine | |
DE915695C (en) | Process for the preparation of 1-phenyl-2-amino-1, 3-propanediol | |
DE873087C (en) | Process for the production of easily soluble halopyridone compounds | |
DE278107C (en) | ||
DE613627C (en) | Process for the preparation of isomers of the derivatives of 8-aminoquinoline obtainable according to patent specification 576119 | |
DE1924174C3 (en) | Magnesium Orotate Glycinate | |
DE964597C (en) | Process for the production of cortisone or hydrocortisone-21-aldehyde | |
DE182217C (en) | ||
DE2533899C3 (en) | Process for the preparation of steryl-β-glucoside esters | |
DE329772C (en) | Process for the preparation of compounds of the alkaloids of the quinine group | |
DE1020342B (en) | Process for the preparation of a protoveratrine and oxyprotoveratrine salt | |
DE239313C (en) | ||
DE1795616A1 (en) | Benzonaphtyridines | |
DE2015297A1 (en) | New 5H-dibenzo substituted in position 5, square brackets on a, square brackets on cycloheptenes and process for their preparation |